Skip to main content

Vivitrol News

Rapid Procedure Noninferior for Extended-Release Naltrexone Initiation

THURSDAY, May 9, 2024 – For patients with opioid use disorder (OUD), a rapid procedure (RP) is noninferior to a standard procedure for initiation of extended-release (XR) naltrexone, according to a...

Rural Americans Are Going Without Meds to Fight Opioid, Alcohol Addictions

TUESDAY, March 26, 2024 — Less than 9% of rural Americans who abuse both opioids and alcohol are prescribed medications to treat both disorders, new research reveals. Naltrexone treats both opioid u...

FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing

ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....

FDA Approves Vivitrol to Treat Opioid-dependent Patients

ROCKVILLE, Md., Oct. 12, 2010--The U.S. Food and Drug Administration today approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification...

FDA Medwatch Alert: Vivitrol (naltrexone)

[Posted 08/12/2008] FDA informed healthcare professionals of the risk of adverse injection site reactions in patients receiving naltrexone. Naltrexone is indicated for the treatment of alcohol...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Alcohol Dependence, Opiate Dependence

Vivitrol patient information at Drugs.com